Détail de la revue
Molecular genetics and metabolism reports |
Documents disponibles dans cette revue



![]()
Glycogenin-1 deficiency mimicking limb-girdle muscular dystrophy
Lefeuvre C, Schaeffer S, Carlier RY, et al.
Molecular genetics and metabolism reports, 2020, 24
Revue : Molecular genetics and metabolism reports, 24 Titre : Glycogenin-1 deficiency mimicking limb-girdle muscular dystrophy Type de document : Article Auteurs : Lefeuvre C ; Schaeffer S ; Carlier RY ; Fournier M ; Chapon F ; Biancalana V ; Nicolas G ; Malfatti E ; Laforêt P Année de publication : 05/2020 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 32477874 / DOI : 10.1016/j.ymgmr.2020.100597
N° Profil MNM : 2020053 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/32477874 Avis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Urine glucose tetrasaccharide: A good biomarker for glycogenoses type II and III? A study of the French cohort
Piraud M, Pettazzoni M, De Antonio M, et al.
Molecular genetics and metabolism reports, 2020, 23
Revue : Molecular genetics and metabolism reports, 23 Titre : Urine glucose tetrasaccharide: A good biomarker for glycogenoses type II and III? A study of the French cohort Type de document : Article Auteurs : Piraud M, Auteur ; Pettazzoni M ; De Antonio M ; Vianey-Saban C ; Froissart R ; Chabrol B ; Young S ; Laforêt P Année de publication : 04/2020 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 32382504 / DOI : 10.1016/j.ymgmr.2020.100583
N° Profil MNM : 2020051 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/32382504 Avis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Adenotonsillectomy should be avoided whenever possible in infantile-onset Pompe disease
Jones HN, Fernandes S, Hannah WB, et al.
Molecular genetics and metabolism reports, 2020, 23
Revue : Molecular genetics and metabolism reports, 23 Titre : Adenotonsillectomy should be avoided whenever possible in infantile-onset Pompe disease Type de document : Article Auteurs : Jones HN, Auteur ; Fernandes S ; Hannah WB ; Kansagra S ; Raynor EM ; Kishnani PS Editeur : United States Année de publication : 02/2020 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 32090020 / DOI : 10.1016/j.ymgmr.2020.100574
N° Profil MNM : 2020022 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/32090020 Avis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Earlier and higher dosing of alglucosidase alfa improve outcomes in patients with infantile-onset Pompe disease: Evidence from real-world experiences
Chien YH, Tsai WH, Chang CL, et al.
Molecular genetics and metabolism reports, 2020, 23
Revue : Molecular genetics and metabolism reports, 23 Titre : Earlier and higher dosing of alglucosidase alfa improve outcomes in patients with infantile-onset Pompe disease: Evidence from real-world experiences Type de document : Article Auteurs : Chien YH ; Tsai WH ; Chang CL ; Chiu PC ; Chou YY ; Tsai FJ ; Wong SL ; Lee NC ; Hwu WL Année de publication : 2020 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 32373469 / DOI : 10.1016/j.ymgmr.2020.100591
N° Profil MNM : 2020051 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/32373469 Avis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Normalization of obstructive cardiomyopathy and improvement of hepatopathy on ketogenic diet in patient with glycogen storage disease (GSD) type IIIa
Marusic T, Zerjav Tansek M, Sirca Campa A, et al.
Molecular genetics and metabolism reports, 2020, 24
Revue : Molecular genetics and metabolism reports, 24 Titre : Normalization of obstructive cardiomyopathy and improvement of hepatopathy on ketogenic diet in patient with glycogen storage disease (GSD) type IIIa Type de document : Article Auteurs : Marusic T ; Zerjav Tansek M ; Sirca Campa A ; Mezek A ; Berden P ; Battelino T ; Groselj U Année de publication : 2020 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 32714838 / DOI : 10.1016/j.ymgmr.2020.100628
N° Profil MNM : 2020072 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/32714838 Avis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Behavioral, social and school functioning in children with Pompe disease
Korlimarla A, Spiridigliozzi GA, Stefanescu M, et al.
Molecular genetics and metabolism reports, 2020, 25
Permalink![]()
MLASA1 is a poly-phenic but not a di-phenic condition
Finsterer J
Molecular genetics and metabolism reports, 2019, 21
Permalink![]()
Response: Late-onset Pompe disease manifests in the brain
Schneider I, Hensel O, Zierz S
Molecular genetics and metabolism reports, 2019, 21
Permalink![]()
Molecular based newborn screening in Germany: Follow-up for cystinosis
Hohenfellner K, Bergmann C, Fleige T, et al.
Molecular genetics and metabolism reports, 2019, 21
Permalink![]()
Myopathy, lactic acidosis and sideroblastic anemia 1 (MLASA1): A 25-year follow-up
Woods J, Cederbaum S
Molecular genetics and metabolism reports, 2019, 21
Permalink![]()
Late-onset Pompe disease manifests in the brain
Finsterer J
Molecular genetics and metabolism reports, 2019
Permalink![]()
Pathogenic and rare deleterious variants in multiple genes suggest oligogenic inheritance in recurrent exertional rhabdomyolysis
Sambuughin N, Mungunsukh O, Ren M, et al.
Molecular genetics and metabolism reports, 2018, 16, p 76
Permalink![]()
Renal artery fibromuscular dysplasia in Pompe disease: A case report
Pappa E, Papadopoulos C, Grimbert P, et al.
Molecular genetics and metabolism reports, 2018, 16, p 64
Permalink![]()
The phenotype, genotype, and outcome of infantile-onset Pompe disease in 18 Saudi patients
Al-Hassnan ZN, Al-Hassnan ZN, Khalifa OA, et al.
Molecular genetics and metabolism reports, 2018, 15, p 50
Permalink![]()
Two siblings with very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency suffered from rhabdomyolysis after l-carnitine supplementation
Watanabe K, Watanabe K, Yamada K, et al.
Molecular genetics and metabolism reports, 2018, 15, p 121
Permalink![]()
Novel ETFDH mutations in four cases of riboflavin responsive multiple acyl-CoA dehydrogenase deficiency
Fan X, Fan X, Xie B, et al.
Molecular genetics and metabolism reports, 2018, 16, p 15
Permalink![]()
Pompe disease treatment with twice a week high dose alglucoside alfa in a patient with severe dilated cardiomyopathy
Landis JL, Landis JL, Hyland H, et al.
Molecular genetics and metabolism reports, 2018, 16
Permalink![]()
Analysis of GBE1 mutations via protein expression studies in glycogen storage disease type IV: A report on a non-progressive form with a literature review
Iijima H, Iijima H, Iwano R, et al.
Molecular genetics and metabolism reports, 2018, 17, p 31
Permalink![]()
Dilative arteriopathy in Pompe disease may not only affect the cerebral arteries
Finsterer J
Molecular genetics and metabolism reports, 2018, 17
Permalink![]()
Novel heterozygous mutations in the PGAM2 gene with negative exercise testing
Sidhu M, Brady L, Vladutiu GD, et al.
Molecular genetics and metabolism reports, 2018, 17, p 53
Permalink![]()
Only some patients with bulbar and spinal muscular atrophy may develop cardiac disease
Finsterer J, Stollberger C
Molecular genetics and metabolism reports, 2017, 14, p 44
Permalink![]()
Hypothyroidism in late-onset Pompe disease
Schneider J, Burmeister LA, Rudser K, et al.
Molecular genetics and metabolism reports, 2016, 8, p 24
Permalink![]()
Muscle imaging data in late-onset Pompe disease reveal a correlation between the pre-existing degree of lipomatous muscle alterations and the efficacy of long-term enzyme replacement therapy
Gruhn KM, Heyer CM, Guttsches AK, et al.
Molecular genetics and metabolism reports, 2015, 3, p 58
Permalink